A Double Blind, Multicentre, Placebo Controlled Trial of Lornoxicam in Patients With Osteoarthritis of the Hip and Knee.

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.51.2.238

Related search